Company news

Masimo Corporation (NASDAQ:MASI) news

Masimo Corporation news releases on 6ix. Latest, Sep 30, 2026: Masimo Wins Two OCTANE High Tech Awards - Company Recognized for 'Deal of the Year' and 'Best…

Masimo Corporation (NASDAQ:MASI) news

Press releases & updates

Masimo Wins Two OCTANE High Tech Awards - Company Recognized for 'Deal of the Year' and 'Best Technology Leadership Team'

Masimo Receives FDA 510(k) Clearance for Root® with LiDCO® and the Masimo LiDCO Sensor to Provide Continuous Oxygen Delivery (DO₂)

Masimo Receives CE Mark for AI-Powered smartSedLine™ Brain Function Monitor to Advance Anesthetic Management

Masimo Appoints Tim Benner as President

Masimo Receives FDA 510(k) Clearance for the Pediatric Patient State Index, the First-and-Only Sedation Score Specifically Designed for the Unique Physiology of the Pediatric Brain

Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner

Masimo : Quarterly Report for Quarter Ending April 4, 2026 (Form 10-Q)

Masimo Shareholders Approve Acquisition by Danaher

Masimo SET® Pulse Oximetry Performed Accurately on Hospitalized Newborns of All Skin Tones in Largest-Ever Prospective Real-World Study

Masimo to be Acquired by Danaher for $180.00 Per Share

Danaher To Acquire Masimo Corporation

Masimo to Report Fourth Quarter and Full Year 2025 Financial Results after Market Close on Thursday, February 26

Clairity Appoints Founder Dr. Connie Lehman as Chief Executive Officer; Joe Kiani Named Chairman of the Board

Masimo Announces Select Preliminary 2025 Financial Results

Masimo to Present in the J.P. Morgan 2026 Healthcare Conference

Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth

Masimo Issues Statement on California Jury Verdict Finding Patent Infringement by Apple and Awarding Masimo $634 Million in Damages

Masimo Reports Third Quarter 2025 Results

Masimo to Report Third Quarter 2025 Financial Results after Market Close on Tuesday, November 4

Masimo to Host Investor Day on December 3, 2025

In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones

Masimo Completes Sale of Consumer Audio Business to HARMAN International

New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs

Masimo Announces Expansion of Strategic Partnership with Philips

Masimo to Present in the Wells Fargo Healthcare Conference

Masimo O3® Regional Oximetry Receives FDA Clearance for Expanded Indication of Its Unique Delta Hemoglobin Parameters

Masimo Reports Second Quarter 2025 Results

Masimo to Report Second Quarter 2025 Financial Results after Market Close on Tuesday, August 5

Masimo Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia

Masimo to Present in the Jefferies Global Healthcare Conference

Masimo to Present in the BofA Securities 2025 Health Care Conference

Masimo to Sell Consumer Audio Business to HARMAN International

Masimo Reports First Quarter 2025 Results

Masimo to Report First Quarter 2025 Financial Results after Market Close on Tuesday, May 6

Masimo to Present in the 24th Annual Needham Virtual Healthcare Conference

Masimo to Present in the 46th Annual Raymond James Institutional Investor Conference

Masimo Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Updated Full-Year 2025 Guidance

Masimo Announces Leadership Transition

Masimo Announces Select Preliminary 2024 Financial Results and 2025 Guidance

Masimo to Present in the 43rd Annual J.P. Morgan Healthcare Conference

Masimo to Present in the Piper Sandler 36th Annual Healthcare Conference

Masimo to Present in the Jefferies London Healthcare Conference

Masimo to Present in Stifel 2024 Healthcare Conference

Masimo Reports Third Quarter 2024 Financial Results

Vanderbilt University Medical Center Integrates Masimo Radius VSM™ in Proactive Care Protocol to Combat Emergency Room Congestion

Masimo to Report Third Quarter 2024 Financial Results after Market Close on Tuesday, November 5

Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors

Masimo Provides Leadership and Business Updates

Masimo Shares Final Thoughts Ahead of September 19 Annual Meeting Where Everything is at Stake